15th Mar, 2024
A recent study commented on the increased risk of depression among people with obesity, an association we have long observed in clinical practice. Previous research indicates that depression and obesity tend to run together, meaning that the heavier we are, the more likely we are to be depressed. But the reverse is also true: the more we lose some of that weight and move toward…
Read more »
8th Mar, 2024
Despite the successes of GLP-1 medications and bariatric surgery, the obesity epidemic continues as a public health disaster globally. The prevalence of obesity long ago reached alarming levels, needlessly killing 300,000 Americans annually, and leading to appallingly increased morbidity and healthcare costs. If we truly wish to reduce the dreadful increases in stroke, heart attack, and degenerative joint disease obesity has brought us, it is…
Read more »
26th Jan, 2024
Scientists and public health researchers are beginning to shed light on the connections between loneliness, isolation, obesity, and longevity, and the profound impact these social factors can have on overall well-being and mortality rates. CNN recently highlighted a new study that found higher levels of loneliness in people with obesity. According to the study, treatment focused on easing loneliness and social isolation may reduce the…
Read more »
22nd Dec, 2023
Ozempic, a medication belonging to the glucagon-like peptide-1 (GLP-1) receptor agonist class, is commonly prescribed for the management of type 2 diabetes. In addition to its primary function of improving glycemic control, Ozempic gained recognition for its significant effects on weight loss. But these drugs are in shortage and can be hard to come by, not to mention expensive. And did you sign on to…
Read more »
18th Aug, 2023
In recent years, the rising costs of prescription drugs have become a major concern for patients and healthcare providers alike. What can people expect to pay for drugs like Ozempic and Wegovy in the treatment of type 2 diabetes and obesity? It's a good question! And to answer it, we must factor for costs as a whole, including drug pricing, treatment duration, insurance coverage, and…
Read more »
4th Aug, 2023
Despite their high costs and poor insurance coverage, Ozempic and Wegovy are important medications used in the management of type 2 diabetes and obesity. Ozempic (generic name: semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist, while Wegovy (generic name: semaglutide injection) is the higher dose form of semaglutide used specifically for weight management. With so many people taking Ozempic and Wegovy for weight loss and…
Read more »
24th Mar, 2023
People considering weight-loss surgery tend to have lots of questions, and one of them often relates to weight. How overweight do you need to be for weight loss surgery? Guidelines regarding weight-loss surgery continue to lower the body weight required to qualify, which means more people are eligible. Current BMI Guidelines for Weight Loss Surgery The newest guidelines generally talk about a body mass index (BMI)…
Read more »
8th Jul, 2022
With rates of obesity and type two diabetes continuing to increase, the short answer is no, diet and exercise are not enough. But it's important to understand why diet and exercise alone aren't enough to combat obesity. What about Willpower? There is a tendency to blame people with obesity for their lack of willpower to eat well or exercise. But the issue is about far…
Read more »
24th Jun, 2022
Alexander Ayzengart, MD, MPH, FACS, specializes in advanced laparoscopic, metabolic, and bariatric surgery. Before joining Nevada Surgical, Dr. Ayzengart provided his expertise in weight loss surgery, gastroesophageal disease, anti-reflux surgery, and abdominal and inguinal hernia surgery at the University of Florida Health Bariatric Surgery Center. As a new member of the Nevada Surgical team, he's bringing his expertise to the northern Nevada community. The prevalence of severe obesity has…
Read more »
11th Jun, 2022
A recent headline on CNN excitedly notes that "overweight people lost 35 to 52 pounds on newly approved diabetes drug, study says." A weekly dose of a medication, recently approved by the FDA, used to treat type 2 diabetes may also help adults without the condition lose weight. Here's what the study revealed, plus a little perspective from Dr. Sasse on this newly approved diabetes…
Read more »
Address
Nevada Surgical
5500 Reno Corporate Drive
Suite 100

Reno, NV 89511
Minimally invasive weight loss surgery experts.info@sassesurgical.com(775) 829-7999
Phone
Office Hours
Monday
7:30 am - 4:30 pm
Tuesday
7:30 am - 4:30 pm
Wednesday
7:30 am - 4:30 pm
Thursday
7:30 am - 4:30 pm
Friday
Closed
Saturday
Closed
Sunday
Closed